United Therapeutics (UTHR) Accounts Payables (2009 - 2026)
United Therapeutics (UTHR) posted Accounts Payables of $498.3 million for Q1 2026, up 2.11% sequentially from $488.0 million in Q4 2025, and up 35.78% YoY from $367.0 million in Q1 2025.
United Therapeutics (UTHR) Accounts Payables (2009 - 2026) Analysis & Trends
United Therapeutics has reported Accounts Payables for 18 years, with the latest figure at $498.3 million in Q1 2026.
- Quarterly Accounts Payables rose 35.78% year-over-year to $498.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $498.3 million (up 35.78% YoY) and the FY2025 annual result came in at $488.0 million, up 41.65% from the prior year.
- Accounts Payables improved to $498.3 million in Q1 2026 per UTHR's latest filing, from $488.0 million in the prior quarter.
- Over five years, Accounts Payables peaked at $498.3 million in Q1 2026 and troughed at $166.4 million in Q1 2022.
- A 5-year average of $327.5 million and a median of $325.3 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables climbed 0.85% in 2022, then surged 51.48% in 2023.
- Over 5 years, Accounts Payables stood at $229.9 million in 2022, then grew by 29.62% to $298.0 million in 2023, then increased by 15.6% to $344.5 million in 2024, then soared by 41.65% to $488.0 million in 2025, then climbed by 2.11% to $498.3 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $498.3 million, $488.0 million, and $468.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 332.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 497.80 Mn |
| Mar 31, 2026 | 498.30 Mn |
| Dec 31, 2025 | 488.00 Mn |
| Sep 30, 2025 | 468.00 Mn |
| Jun 30, 2025 | 432.00 Mn |
| Mar 31, 2025 | 367.00 Mn |
| Dec 31, 2024 | 344.50 Mn |
| Sep 30, 2024 | 363.90 Mn |
| Jun 30, 2024 | 325.30 Mn |
| Mar 31, 2024 | 305.10 Mn |
| Dec 31, 2023 | 298.00 Mn |
| Sep 30, 2023 | 333.40 Mn |
| Jun 30, 2023 | 292.00 Mn |
| Mar 31, 2023 | 239.70 Mn |
| Dec 31, 2022 | 229.90 Mn |
| Sep 30, 2022 | 220.10 Mn |
| Jun 30, 2022 | 196.60 Mn |
| Mar 31, 2022 | 166.40 Mn |
| Dec 31, 2021 | 174.60 Mn |
| Sep 30, 2021 | 210.50 Mn |